semaglutide fda approval history of glucagon-like peptide-1 receptor agonists Two-year effects of semaglutide in

In the obese trial cohort, 1 mg moved 24-hour heart rate by +0.7 bpm in the first week, essentially placebo. In a healthy lean Phase 1b group, the same dose raised heart rate by about 10 bpm, with a peak near 15 to 20 bpm around days 4 to 6. Lean, younger participants had more reactive heart-rate control than the sedentary, obese, and metabolically stressed trial population

But treating it as a standalone solution

Tracking and adjusting Keep a protocol journal

While results vary, many of our Mission Valley clients experience significant and sustainable weight loss

In practice that means somewhere around 0.1 to 0.5 mg weekly for semaglutide, or 0.5 to 2.5 mg for tirzepatide, though the numbers matter less than the intent

EverWell Primary Care members get access to discounted rates on compounded GLP-1s